The PulSentry blog

Evidence-led writing on cardiac tamponade, pulsus paradoxus, and what a pulse oximeter waveform can reveal, for clinicians, and for anyone trying to understand the science.

Clinical explainer

What is pulsus paradoxus? A clinician's guide

The definition, how it is measured, the conditions it accompanies, when it is absent, and how the same signal appears on the pulse oximeter waveform.

Read →
Clinical explainer

Why echocardiography misses post-surgical tamponade

After cardiac surgery, transthoracic echo is far less sensitive than many expect. What the evidence shows, and why the post-discharge window is a blind spot.

Read →
Reimbursement

The 2026 Medicare RPM CPT code guide

99453, 99454, 99457, 99458, 99091, and the new 99445, what each pays, the day-count thresholds, and how short post-discharge monitoring fits.

Read →
Clinical evidence

Why TTE misses post-surgical pericardial hematoma

The 33% hematoma-sensitivity finding, scoped carefully, why loculated posterior collections defeat echo, and the case for waveform monitoring.

Read →
Research-stage

Beyond tamponade: the respiratory signal in the pulse-oximeter waveform

A scoped, honestly-hedged look at respiratory variation in the PPG across asthma severity, fluid responsiveness, and a research direction in breathlessness.

Read →
Technology

FFT and power spectral density of the PPG waveform, explained

How a pulse-oximeter signal is transformed into the frequency domain, and what the pulsus index measures.

Read →
Primer

Pulse oximetry 101: what the number and the waveform mean

What SpO2 actually measures, what the PPG waveform shows beyond it, common pitfalls, and why the waveform is underused.

Read →
Clinical explainer

Cardiac tamponade after cardiac surgery: incidence, timing, detection

How often it happens, when it presents, which patients are most at risk, and why detection is harder than it sounds.

Read →
Expansion

Tamponade after Watchman, ablation, and transseptal procedures

Iatrogenic tamponade risk in structural-heart and electrophysiology procedures, and the monitoring window that matters.

Read →
Technology

Software as a medical device: the regulatory pathway for a PPG algorithm

How a pulse-oximeter waveform algorithm is classified as software as a medical device, the 510(k) versus De Novo question, and what a predicate path looks like.

Read →
Reimbursement

The post-discharge monitoring gap after cardiac surgery

Patients leave the hospital closely monitored, then go dark for weeks. The post-discharge blind spot, and the economics of closing it with remote monitoring.

Read →
Clinical explainer

Who is most at risk: tamponade after valve surgery and on anticoagulation

Late tamponade is more common after valve surgery and higher on anticoagulation. The highest-risk cardiac-surgery cohorts, and why they matter for monitoring.

Read →
Clinical explainer

From cuff to spectrum: the pulsus index vs bedside pulsus paradoxus

How the spectral pulsus index relates to the classic cuff-measured pulsus paradoxus, what each captures, and why a continuous signal matters.

Read →
Clinical explainer

The history of pulsus paradoxus: from Kussmaul to a continuous signal

Adolf Kussmaul named the sign in 1873. Why the bedside cuff-and-ear method stayed stable for 150 years, and what a continuous reading of the same signal adds.

Read →
Reimbursement

The cost of late tamponade detection: a health-economics view

Late tamponade forces an emergency pathway: unplanned readmission, urgent imaging, drainage or reoperation, and ICU escalation. Where that avoidable cost sits, and what earlier detection would have to achieve.

Read →
Clinical explainer

Pericardial effusion vs tamponade: when an effusion turns dangerous

Not every pericardial effusion is tamponade. What separates a stable effusion from a hemodynamic emergency, why the speed of accumulation matters more than the volume, and why that window is easy to miss after discharge.

Read →